Prognosis factors in multiple myeloma
Bladé, J.; Rozman, C.; Reverter, J.C.; Montserrat, E.
Revista Clinica Espanola 183(4): 215
1988
ISSN/ISBN: 0014-2565 PMID: 3244873 Document Number: 322782
Document emailed within 1 workday
Related Documents
Bataille, R. 1990: Multiple myeloma: diagnosis and prognosis Pathologie-Biologie 38(8): 826-828Bladé, J. 1988: Multiple myeloma and idiopathic monoclonal gammapathy. Diagnosis, prognosis and treatment Medicina Clinica 90(17): 704-714
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Pick, A.I.; Tamir, R.; Vana, D.; Duczyminer-Kahana, M.; Weiss, H.; Lurie, H.; Dawidowich, J.; Meyerson, E.; Gelernter, I. 1990: Prognostic factors in multiple myeloma Harefuah 118(8): 437-442
Basit, A.; Siddiqui, N.; Hameed, A.; Muzaffar, N.; Athar, S. 2014: Factors affecting outcome of patients with multiple myeloma Journal of Ayub Medical College Abbottabad: Jamc 26(3): 376-379
Peest, D. 1998: Prognostic factors and standard therapy of multiple myeloma Praxis 87(25-26): 874-878
Bladé, J.; Rozman, C. 1984: Multiple myeloma: analysis of prognostic factors and classification by stages Sangre 29(5): 918-926
Chavynchak, R.B.; Rekhtina, I.G. 2008: Prognostic factors in multiple myeloma complicated with renal failure Terapevticheskii Arkhiv 80(1): 84-88
Pasqualetti, P.; Colantonio, D.; Casale, R.; Lorenzetti, G.; Natali, G. 1989: Prognostic factors in multiple myeloma. Selection using multivariate analysis Recenti Progressi in Medicina 80(10): 543-546
Yamazaki, K. 1970: Drug therapy of multiple myeloma--various factors influencing the effects of drugs Gan no Rinsho. Japan Journal of Cancer Clinics 16(9): 889-895
Wang, Q.-x.; Yan, Y.-p.; Ji, Z.-h.; Ni, Q.-r.; Song, Y.-p.; Li, S.-t.; Xie, J.; Ren, J.-j.; Guo, L.; Dai, J.-q. 2013: Study on the quality of life and its related factors on patients with multiple myeloma Zhonghua Liu Xing Bing Xue Za Zhi 34(12): 1233-1236
Takei, T.; Coles, M. 1996: Treatment of pathologic fracture and surgical value of prognostic factors in multiple myeloma International Surgery 81(4): 403-406
Discalzi, G.; Cioci, I.; Ganio, L.; Ponzetti, C.; Coscia, G. 1991: Multiple myeloma and occupational risk factors: a case-control study La Medicina del Lavoro 82(3): 248-252
Zdziarska, B. 1990: Retrospective analysis of patients with multiple myeloma; clinical characteristics and prognostic factors Annales Academiae Medicae Stetinensis 36: 179-194
Matzner, Y.; Benbassat, J.; Polliack, A. 1977: Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. a review of 80 patients Israel Journal of Medical Sciences 13(8): 797-807
Matsui, M. 2003: Prognosis and factors that predict outcome in multiple sclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 61(8): 1396-1401
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Flachenecker, P.; Hartung, H.P. 1996: Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors Der Nervenarzt 67(6): 444-451
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424